Precision for Medicine, Oncology and Rare Disease

1st January, 1970

Precision for Medicine, Oncology and Rare Disease

Precision for Medicine, Oncology and Rare Disease is the first comprehensive, fully-integrated CRO devoted to oncology and rare disease innovation. Precision supports life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively, and applies novel biomarker approaches to clinical research that take advantage of the latest advancements in science and technology. We focus predominantly on clinical trial excellence, with fully integrated genomics, immune-response assays, global specimen logistics, biomarker analytics and companion diagnostics. With over 2000 experts in 34 offices worldwide, Precision offers novel clinical trial designs, industry-leading operational and medical experts and advanced biomarker solutions for pharma and biotech innovators.


Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the

If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:

Paul Adams
+44 (0)20 7936 6948

Speaker opportunities

We identify and invite individuals we believe to be the best speakers in the market, if you think you can make a difference to the quality of our events please contact:

Hannah Toms
+44 (0)20 7936 6855